Skip to main content

Table 1 Concentration of miR-210 expression before and after melatonin and placebo administration

From: Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial

miRNA-210

Mean (SD)

Melatonin (n = 13)

Placebo (n = 12)

p

Before

162.8 (54.92)

175.2 (34.30)

0.767

After

53.8 (16.65)

53.5 (14.28)

Difference (after − before)

− 109.09 (51.62)

− 103.71 (36.24)